Vaccination referrals2021-09-23T15:15:19+10:00

COVID-19 (Coronavirus) Vaccination referrals to Metro North Health

Metro North Health provides vaccination services with Pfizer COVID-19 vaccine (Comirnaty) and AstraZeneca COVID-19 Vaccine across multiple facilities including community clinics, hospital-based clinics and specialist led clinics.

How can your patients get an appointment at a Metro North Health Vaccination Clinic?

Eligible people can now book to receive a COVID-19 vaccine at a Queensland Health vaccination location provided they bring written proof of their eligibility.

Do Metro North Health Vaccination Clinics accept walk-ins?

This will be continually reviewed and updated on our North Health Vaccinations information page which provides a list of all Metro North Health Vaccination Clinics with their opening hours.

Priority will be given to people in the priority groups identified in the Pfizer vaccine drop down list below.

Who are Metro North Health vaccinating?

Metro North Health is vaccinating people aged over 12 years of age based on eligibility for each vaccination below.  Identified priority groups will be given priority for vaccination and can be found under Pfizer vaccine drop down below.

This will be continually reviewed and updated on our Metro North Health Vaccinations information page.

Which vaccine is your patient eligible for?

  • People aged 60 years and over, unless they have a referral from their GP (PDF)
  • Any person who has had a first dose of AstraZeneca (Vaxzevria), without any serious adverse events.

The Australian Technical Advisory Group on Immunisation (ATAGI) reinforces that people of any age who have had their first dose of COVID-19 Vaccine AstraZeneca without any serious adverse events can receive the second dose.

The risk of Thrombosis with Thrombocytopenia Syndrome (TTS) following a second dose of AstraZeneca is much lower than the risk following a first dose.  Recent UK analysis reported 15 cases to date out of 9.0 million second doses of COVID-19 Vaccine AstraZeneca given. This translates into an estimated rate of 1.7 case per million doses.

All people aged 12 years and over are now eligible for the Pfizer Vaccination.

Priority groups for vaccination

  • Any person requiring a second dose of vaccine (based on vaccine type and age eligibility)
  • Pregnant women during any stage of pregnancy
  • Any worker in the following industries:
    • Residential aged care and disability care workers
    • Healthcare workers and support staff including students on clinical placement
    • Hotel quarantine workers (including passenger transport services)
    • Workers at airports that receive international and domestic flights
    • Queensland-based international and interstate air crew workers
    • Border workers
    • Freight workers who cross domestic borders
    • Distribution centre workers
    • Fly-in-fly-out workers
    • Volunteers at a COVID-19 testing or vaccination clinic
    • Maritime industry workers
    • Critical and high risk workers e.g. emergency services, corrective services, youth detention centres, meat processing businesses, freight and food distribution
    • School and early childhood staff

If there are other medical considerations you need advice on for COVID-19 vaccination, please contact the Metro North Vaccination Medical Officer for advice (please do not include patient identifiable information in any email).

Second dose of your patient’s COVID-19 vaccine

Please note your patient’s second dose of vaccine must match their first dose of vaccine unless they have experienced a significant documented reaction to their first dose or are pregnant.

Which patients should I refer to Qld Adult Specialist Immunisation Service (QASIS)?

The state-wide service (based at Metro North Hospital and Health Service) for those aged over 16 years requiring consideration for hospital-based COVID-19 vaccination for those with significant allergies, anaphylaxis or side effects as listed in criteria below.

  • The patient will be reviewed to determine suitability for vaccination. This is usually conducted by phone consult and may be performed by a Senior Medical Officer or Nurse Practitioner, or another medical officer. A senior staff member reviews all cases.
  • If the patient lives regionally,

QASIS will assist in identifying suitable locations for vaccination and it will be the responsibility of the patient and referring doctor to coordinate vaccination appointment. If required, QASIS will provide appropriate documentation to support vaccination in regional centres. Referrers should refer to their local Public Health Unit for an up-to-date list of locally operated vaccination centres.

Who should be referred to QASIS

The patient must meet the following to be referred to QASIS:

Anyone who has experienced:

It is also recommended that adults who may be at risk of experiencing an AEFI under the following circumstances are referred to QASIS prior to vaccination:

  • Anaphylaxis or generalised allergic reaction (without anaphylaxis) to any component of the COVID-19 vaccine to be administered (including allergic reactions to other vaccines).
  • A history of PEG or polysorbate 80 related allergic reactions (include details and dates of the substance that the person reacted to).
  • A systemic mast cell activation condition with a raised tryptase that have been unable to tolerate previous intramuscular injections due to recurrent anaphylaxis.
  • A history of capillary leak syndrome.
  • A history of pericarditis or myocarditis following COVID-19 vaccination

What allergic conditions require a referral to QASIS?

  • Individuals who have experienced an immediate (within 2 hours) and generalised symptoms of an allergic reaction following a COVID-19 vaccination.
  • A history of anaphylaxis or allergic reaction to any component of a COVID-19 vaccine (e.g. PEG or polysorbate 80)
  • A systemic mast cell activation disorder

Who should not be referred to QASIS?

  • History of allergy, including anaphylaxis to food, venom or latex. See QASIS recommendation here.
  • Allergic conditions including asthma, atopic dermatitis or allergic rhinitis.  See QASIS recommendation here.
  • History of venous thromboembolism in typical sites (DVT or PE) not related to exposure to a COVID-19 vaccine.
  • Predisposition to form blood clots (e.g. Factor V Leiden) or other non-immune thrombophillic disorders.
  • Family history of blood clotting disorders or clotting conditions.
  • History of congenital cardiac abnormalities.  Please consult patients regular cardiologist.
  • History of myocarditis or pericarditis not related to the COVID-19 vaccine.  See here and consult the patients regular cardiologist.
  • Current or past history of thrombocytopenia (low platelet count).  See the joint statement from the ATAGI and THANZ here.
  • Individuals who experience minor or expected side-effects as outlined in the product information who wish to change to another vaccine.  Unless contraindicated as outlined above exist, the advice remains to vaccinate with the same COVID-19 vaccine.  See the here for further advice on when a vaccine may be switched.

Please note QASIS does not accept referral requests for a particular vaccine brand. Vaccine eligibility is determined by Commonwealth Guidelines and clinical need.

How do I refer my patient to QASIS?

You must provide a referral to access this service. There is no walk-in available.

Send an outpatient referral to MNHHS Central Patient Intake Unit (CPIU) via:

  • Electronic – preferred

(For GPs outside Metro North HHS catchment – Medical Objects ID: MQ40290004P  or HealthLink EDI is: qldmnhhs)

  • Fax – 1300 364 952

Referrals must include essential clinical information listed below explaining the reason for referral and details of the condition or reaction that requires hospital review.

Other information:

Essential information required in your COVID-19 vaccination referral letter

  • Full name, including aliases
  • Date of birth
  • Residential and postal address
  • Telephone contact number/s – home, mobile and alternative
  • Medicare number, where eligible
  • Name of the parent or caregiver, if appropriate
  • Preferred language and interpreter requirements
  • Identifies as Aboriginal or Torres Strait Islander
  • Full name
  • Full address
  • Contact details – telephone, fax, email
  • Provider number
  • Date of request
  • Signature
  • History and supporting evidence of specific relevant underlying medical condition
  • Relevant medical conditions or GP concern and how it fits with QASIS referral guidelines
  • Relevant detailed history that outlines the reaction to the COVID-19 vaccine (e.g. urticaria, angioedema, hypotension with vitals such as blood pressure, heart rate and oxygen saturation) AND time of onset after vaccination and observations
  • Treatment provided to treat the outlined reaction
  • Current medications and dosages and if any new medications where initiated at the time of the reaction
  • Known or previous adverse drug reactions or other allergies, outlining the details of the reaction and when they occurred.  It is not enough to just include a list of ADRs with no explanation.
  • Vaccination history and if the patient tolerated the vaccine.
  • Any investigations done and the relevant results
  • Other relevant Medical History and any other information important in relation to COVID vaccination.

Referrals that contain incomplete or inadequate information will be rejected.

As information changes frequently, it is important that you are aware of latest COVID-19 updates.

COVID-19 (Coronavirus) Vaccination referrals to Metro North Health

Metro North Health provides COVID -19 vaccination services with Pfizer/BioNTech COMIRNATY and AstraZeneca/Oxford COVID-19 vaccines across multiple facilities including community clinics and hospital-based, specialist led clinics.

The public will need an appointment to attend a Metro North Health COVID-19 vaccination clinic – see details below.

On 17 June 2021, the Australian Technical Advisory Group on Immunisation (ATAGI) issued advice recommending that the Pfizer COVID-19 vaccine is the preferred vaccine for adults under the age of 60.

What does this mean?

  1. People aged 16-59 can receive a Pfizer COVID-19 vaccination, as a first dose
  2. People aged 60 and over can receive an AstraZeneca COVID-19 vaccination
  3. Your second dose of vaccine must match your first dose of vaccine (unless you’ve had a significant documented reaction to your first dose)

ATAGI supports the completion of a two-dose schedule of AstraZeneca based on current evidence.

The risk of Thrombosis with Thrombocytopenia Syndrome (TTS) following a second dose of AstraZeneca is much lower than the risk following a first dose. Recent UK analysis reported 15 cases to date out of 9.0 million second doses of COVID-19 Vaccine AstraZeneca given. This translates into an estimated rate of 1.7 case per million doses.

ATAGI reinforces that people of any age who have had their first dose of COVID-19 Vaccine AstraZeneca without any serious adverse events can receive the second dose.

Metro North Vaccination Clinics will be unable to provide Pfizer Vaccination to individuals aged over 60 years old unless they meet the criteria below.

Criteria for referral

Eligible people can now book to receive a COVID-19 vaccine at a Queensland Health vaccination location provided they bring written proof of their eligibility.

Patients may also be referred for COVID-19 vaccination in Metro North Health if they have one of the following (click to reveal more details):

Metro North Health will accept referrals for those patients with a history of severe allergies, anaphylaxis, or a history of mastocytosis where their usual treating GP recommends vaccination within a hospital environment.

How to refer

A. Patients requiring specialist vaccine review:

  • A known systemic mast cell activation disorder with raised mast cell tryptase, that requires treatment.
  • Documented anaphylaxis to one of the ingredients contained in the COVID-19 vaccine to be administered (Pfizer – PEG or AstraZeneca – Polysorbate 80).
  • Anaphylaxis to a prior dose of a COVID-19 vaccine.
  • Previous confirmed history of cerebral venous sinus thrombosis (CVST)
  • Previous confirmed medical history of heparin induced thrombocytopenia (HIT)
  • Confirmed history of idiopathic splanchnic (mesenteric, portal and splenic) venous thrombosis.
  • Anti-phospholipid syndrome with thrombosis.
  • History of any form of Thrombosis with Thrombocytopenia Syndrome (TTS) after a previous dose of AstraZeneca/Oxford COVID-19 vaccine
Send an outpatient referral to MNHHS Central Patient Intake via

  • GP Smart Referrals (generic template)
  • Medical Objects
  • Fax

Referrals must include essential clinical information listed below explaining the reason for referral and details of the condition or reaction that requires hospital review.

B: Patients requiring precautions:

  •  Immediate (within four hours) and generalised symptoms of a possible allergic reaction without anaphylaxis to a previous dose of a COVID-19 vaccine.
  • Prior history of anaphylaxis to previous vaccines and/or multiple drugs (injectable and/or oral) where ingredients such as PEG or polysorbate 80 may conceivably be the cause.
  • Generalised allergic reaction (without anaphylaxis) to one of the ingredients in the COVID-19 vaccine to be administered (Pfizer-PEG or AstraZeneca-Polysorbate 80).
Send an outpatient referral to MNHHS Central Patient Intake via

  • GP Smart Referrals (generic template)
  • Medical Objects
  • Fax

Referrals must include essential clinical information listed below explaining the reason for referral and details of the condition or reaction that requires hospital review.

NOTE: People will be booked into one of the HOSPITAL vaccination clinics within Metro North Health to allow for a local medical team to be readily available.

How to refer
Vaccination with Pfizer/BioNTech COMIRNATY COVID-19 vaccine is the preferred option in people who:

  • Are under 60 years of age
Individuals can be vaccinated at a Metro North Vaccination Clinic and will need an online booking.

Individuals under 40 yrs of age MUST bring documentation to their appointment to support:

Individuals aged 40-59 yrs can book directly here without the need for documentation – Metro North Health COVID-19 Vaccination page

ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021 has the following information – People of any age without contraindications who have had their first dose of COVID-19 Vaccine AstraZeneca without any serious adverse events should receive a second dose of the same vaccine. This is supported by data indicating a substantially lower rate of TTS following a second COVID-19 Vaccine AstraZeneca dose in the United Kingdom (UK).

How to refer
Vaccination with Pfizer/BioNTech COMIRNATY COVID-19 for patients not meeting any of the above criteria may become available from time to time (depending on vaccine stock levels) and will be considered on a case by case basis but is not guaranteed.

Please see the following guidelines re Astra Zeneca vaccines which details :

Patients not meeting the above criteria who request vaccination with Pfizer/BioNTech COMIRNATY COVID-19 where this is not available to administered in respiratory or GP clinics must register their interest at the Metro North Health COVID-19 Vaccination Registration page.

Patients must not turn up to a Metro North HHS clinic without a confirmed appointment and must bring letter headed documentation from their GP to any appointment they receive, clearly explaining the need for a Pfizer Vaccination when it is outside the Commonwealth & State recommended vaccination guidelines.

Vaccine allocation (vaccination clinic and type of vaccine) will be determined by the service on a case-by-case basis depending on the criteria met by the patient in accordance with Commonwealth Guidelines and local availability.

Essential information required in your COVID-19 vaccination referral letter

  • Full name, including aliases
  • Date of birth
  • Residential and postal address
  • Telephone contact number/s – home, mobile and alternative
  • Medicare number, where eligible
  • Name of the parent or caregiver, if appropriate
  • Preferred language and interpreter requirements
  • Identifies as Aboriginal or Torres Strait Islander
  • Full name
  • Full address
  • Contact details – telephone, fax, email
  • Provider number
  • Date of request
  • Signature
  • History and supporting evidence (if available) of specific relevant underlying medical condition
  • Relevant medical conditions or GP concern
  • If Relevant presenting symptoms (e.g. urticaria, angioedema, hypotension) AND time of onset after vaccination and observations
  • Treatment provided
  • Current medications and dosages
  • Known or previous adverse drug reactions or other allergies
  • Any investigations done
  • Other relevant Medical History and any other information important in relation to COVID vaccination.

As information changes frequently, it is important that you are aware of latest COVID-19 updates.